VYM’s $94.6 Billion Portfolio Beats Treasury Yields with Dividend Kings Leading the Way
With 10-year Treasuries near 4.62%, VYM's $94.6 billion portfolio faces a real test from risk-free yields, and two familiar names inside the fund are quietly raising red flags about future income growth.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Vanguard High Dividend Yield ETF (NYSEARCA:VYM) has become one of the largest income vehicles in the market, with $94.6 billion in net assets per its most recent NPORT filing. VYM tracks the FTSE High Dividend Yield Index, screening large-cap U.S. stocks with above-average forecast yields and weighting them by market cap. With the 10-year Treasury near 4.62%, the question is whether VYM’s distribution stream still earns its equity risk premium. The short answer: mostly yes, with two holdings worth watching.
How VYM Generates Income
VYM owns roughly 550 U.S. stocks and passes through their cash dividends, minus a thin expense ratio. There are no options, leverage, or bond exposure, so the distribution is only as safe as the underlying payouts. The index rebalances annually, pruning dividend-cutters and adding higher-yielders, giving the fund self-cleaning ability but no immunity to a bad quarter.
Concentration is meaningful at the top. Broadcom alone sits at about 8% of assets, followed by JPMorgan near 3%, Exxon near 3%, and Johnson & Johnson near 2%. The next tier includes Caterpillar, AbbVie, Bank of America, Home Depot, Chevron, and Cisco. That top ten drives the majority of VYM’s cash yield.
The Blue-Chip Core Is Doing Its Job
Johnson & Johnson (NYSE:JNJ | JNJ Price Prediction) raised its quarterly payout from $1.30 to $1.34 in Q2 2026, extending its Dividend King streak. With trailing EPS of $8.63 against an annualized dividend near $5.36, coverage is comfortable, and management raised full-year adjusted EPS guidance despite biosimilar erosion in Stelara. This dividend would survive a recession.
Procter & Gamble (NYSE:PG) lifted its quarterly dividend to $1.0885, marking another consecutive annual raise. Free cash flow of roughly $3 billion a quarter easily funds the payout, with $6.84 in diluted TTM EPS supporting $4.23 in dividends.
Coca-Cola (NYSE:KO) raised its dividend to $0.53 for 2026, a 63-plus-year streak. Q1 free cash flow jumped 131.9% year over year, and management guides to about $12.2 billion in 2026 FCF. This payout faces no realistic near-term risk.
AbbVie (NYSE:ABBV) is more interesting. Humira revenue fell 38.6% to $688 million last quarter, but Skyrizi and Rinvoq now generate a combined $6.6 billion per quarter with strong double-digit growth. Full-year adjusted EPS guidance was raised to $14.08 to $14.28, giving roughly 2x coverage on the $6.92 annualized dividend. The GAAP payout ratio looks stressed because of IPR&D charges, but the cash story is fine. (For investors thinking about high-yield warning signs elsewhere in their portfolios, our dividend traps briefing is worth a look.)
Two Positions Worth Watching
AT&T (NYSE:T) has held its quarterly dividend at $0.2775 for four consecutive years, and the stock is down about 18% over the past year. Management guides to $18 billion or more in 2026 FCF, but net debt/EBITDA at 2.71x remains above the 2.5x target. The dividend is safe. Dividend growth is not.
American Electric Power (NASDAQ:AEP) nudged its quarterly payout to $0.95, but the story is a $78 billion five-year capex plan and a $2.6 billion equity offering to fund it. Data-center load growth supports the plan, but dilution keeps per-share dividend growth in the low single digits.
Total Return and Verdict
VYM has delivered a 21.6% total return over the past year and 76.6% over five years, so investors have not sacrificed capital appreciation for yield. The distribution is well-supported: the top holdings are Dividend Kings with strong free cash flow, and even weaker names can cover their current payouts. The realistic risk is stagnant dividend growth from a few holdings. VYM makes sense for investors who want a diversified, low-fee income stream backed by real cash earnings. Yield-chasers looking for higher headline payouts should look elsewhere, because VYM is built for durability.
Contact [email protected] for any questions or corrections.
After 15 years on Wall Street with 7 of them as Director of Corporate and Municipal Bond Trading for a NYSE member firm, I started my own project and corporate finance consultancy. Much of the work involves writing business plans, presentations, white papers and marketing materials for companies seeking budgetary allocations for spinoffs and new initiatives or for raising capital for expansion or startup companies and entrepreneurs. On financial topics, I have been published under my own byline at The Motley Fool, 247wallst.com, DealFlow Events’ Healthcare Services Investment Newsletter and The Microcap Newsletter, among others. Additionally, I have done freelance ghostwriting writing and editing for several financial websites, such as Seeking Alpha and Shmoop Financial. I have also written and been published on a variety of other topics from music, audiophile sound and film to musical instrument history, martial arts, and current events. Publications include Copper Magazine, Fidelity (Germany), Blasting News, Inside Kung-Fu, and other periodicals.
